Total Funding
29
8
Total FundingSeries B raised
Growth Score 29 in past quarter
1 pts
Heat Score 8 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
117563
Akouos is a biotechnology company focusing on restoring and preserving hearing.
- Manny Simons: Founder and Chief Executive Officer
- Michael McKenna: Chief Medical Officer and Co-Founder
About the Company
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process,
enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.
